StockStory.org on MSN
BDX Q3 Deep Dive: Portfolio Resilience and Strategic Actions Amid Macro Headwinds
Medical technology company Becton, Dickinson and Company (NYSE:BDX) in Q3 CY2025, with sales up 8.3% year on year to $5.89 billion. Its non-GAAP profit of $3.96 per share was 1.2% above analysts’ ...
With three years spent researching, comparing, and testing software products, Tyler Webb is an expert on all things telecommunications. With work featured on GetVoIP.com, he's written over 150 ...
Q4 revenue was $5.9 billion, with 7% reported growth and 3.9% organic growth. Full-year revenue reached $21.8 billion, up 7.7%, with 2.9% organic growth. Adjusted diluted EPS was $3.96 for Q4 and ...
Q4 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAdam ReiffeThomas Polen - President, CEO ...
SHANGHAI, CHINA / ACCESS Newswire / November 6, 2025 / As the annual China International Import Expo opened in Shanghai on ...
3d
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal
Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments ...
Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively FY25 ...
Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback